Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2024-04-11 Board/Management Inform…
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Changements de direction et mise à jour des résultats de l’année 2023
Board/Management Information Classification · 100% confidence The document explicitly announces significant changes in senior management and the board of directors ('Changements de direction'). Key personnel appointments (Lyn Rees as CEO, Dr. Joanne Mason joining the board) and departures are detailed. This directly aligns with the definition of Board/Management Information (MANG). Although the document also mentions a delay in the Annual Report publication, the primary focus and headline concern the management changes.
2024-04-11 French
Liquidity Agreement and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content discusses a 'Liquidity Agreement Monthly Update' and provides the 'Total Voting Rights' as of March 31, 2024. This type of routine, periodic announcement concerning share structure, treasury shares, and voting rights, distributed via an official news service like RNS, fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR, ER) or a specific corporate action announcement like a dividend (DIV) or share repurchase (POS), but rather a mandatory disclosure update.
2024-04-02 English
Liquidity Agreement Monthly Update and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Liquidity Agreement Monthly Update and Total Voting Rights" and provides specific details about share transactions conducted under an ongoing liquidity agreement (share buyback/stabilization program) between Novacyt and Invest Securities for the period of March 1 to March 31, 2024. It also explicitly states the 'Total Voting Rights' as of the end of March 2024. This content—a regular update on share repurchase activity and total shares outstanding/voting rights—is a specific type of corporate disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard quarterly report (IR). It most closely aligns with announcements related to capital structure changes or share transactions. Since it details the activity of the company buying back its own shares (even if via a third party under agreement), the most appropriate category is 'Transaction in Own Shares' (POS). It is a specific announcement, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2024-04-02 English
Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote" (Monthly information on the liquidity contract and the total number of voting rights). It details the monthly activity (purchases and sales of shares) under a liquidity contract for the period March 1 to March 31, 2024, and reports the total number of voting rights. This type of regular disclosure regarding share transactions (often related to buybacks or market stabilization) and voting rights is a specific regulatory requirement. It is not a full annual report (10-K), an earnings release (ER), or a general management discussion (MDA). It specifically relates to the company's own shares being transacted under a specific agreement, which aligns closely with the definition of 'Transaction in Own Shares' (POS), although it is framed as a monthly update on the liquidity contract. Given the options, 'Transaction in Own Shares' (POS) is the most appropriate fit as it reports on the company's actions regarding its own stock via the liquidity provider, or alternatively, it could be seen as a general regulatory filing (RNS) if POS is too narrow. However, since the core content is the monthly report on share transactions (buy/sell) under the liquidity agreement, POS is the best fit over the generic RNS, as it describes the nature of the transaction being reported on.
2024-04-02 French
Liquidity Agreement and Total Voting Rights
Transaction in Own Shares Classification · 99% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content details a 'Liquidity Agreement Monthly Update' concerning share purchases/sales under that agreement and provides the 'Total Voting Rights' figure (70,626,248). This type of routine, periodic update regarding share structure, treasury shares, and voting rights, disseminated via the RNS system, fits best under the general category for regulatory announcements that aren't specific financial reports (like 10-K or ER) or director dealings. Since it is a formal, periodic regulatory announcement distributed through the RNS system, the most appropriate classification is Regulatory Filings (RNS), as it is a standard disclosure mechanism.
2024-03-01 English
Liquidity Agreement Monthly Update and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Liquidity Agreement Monthly Update and Total Voting Rights" and provides a monthly summary of share purchases and sales conducted under an ongoing liquidity agreement (share buyback/stabilization program) for the period of February 1 to February 29, 2024. It also explicitly states the 'Total Voting Rights' as of the end of February 2024. This content—a regular update on share transactions under a specific agreement and the resulting total share count—does not fit the definitions for 10-K, ER, IR, or DIV. It is a specific regulatory disclosure related to share capital management and voting rights. The closest fit among the provided codes is 'POS' (Transaction in Own Shares) due to the focus on share repurchase/sale activity under the liquidity agreement, or potentially 'DVA' (Declaration of Voting Results & Voting Rights Announcements) due to the inclusion of Total Voting Rights. However, since the primary focus is the monthly activity of the liquidity agreement (share transactions), 'POS' is the most accurate classification for the core content, even though it's a monthly update rather than a formal transaction report. Given the specific nature of reporting total voting rights alongside share transactions, it also strongly relates to capital structure changes. Since 'POS' covers transactions in own shares (which the liquidity agreement facilitates), I will select POS. If 'POS' was not available, 'RPA' or 'RNS' might be considered, but 'POS' is more specific to the activity described.
2024-03-01 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.